HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

485.171

+2.8150.58%

Number of Gainers:21

Number of Losers:10

Number of Flat:2

PE:- -

High:489.931

Open:482.072

Low:481.405

Close:482.357

Volume:61.61M

Turnover:1.28B

Market Cap:307.98B

Float Cap:273.83B

Loading ...

Hbm9378/Win378, an Ultra-Long-Acting Antibody Targeting Tslp, Achieves Positive Phase 2 Results in Asthma and Initiates Phase 3 Study

THOMSON REUTERS

Genfleet-B Completes Share Buyback Worth HK$1.54 Million

The AI Drug Discovery Sector Enters Its Value-Realization Phase, Unlocking Fresh Growth Avenues for Innovative Medicines

ALEBUND-B Wins US FDA Nod to Start Trial of Novel IgA Nephropathy Drug AP308

Alphamab-B Repurchases 220,000 Shares for HK$1.85 Million on September 8

Alphamab Oncology Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 8.41

Ionis Pharmaceuticals Shares Slide 13.1% in Pre-Market Trading

ASC36 Obesity Therapy Enters Phase I Trials in the US by Ascletis

Ascletis Pharma - Initiates U.S. Phase I Study for Asc36 Oral Tablets for Obesity

THOMSON REUTERS

Consolidation at the Base Meets Trend Rebound: When Will Kintor Pharma-B Hit the Key Turning Point for a Valuation Recovery?

Nanxin Pharmaceutical Receives Penalty for Disclosure Violations, Affected Investors May Seek Compensation

InnoCare Gets First Half of Remaining Stake Bought in Subsidiary

MT Newswires Live

HK Market Alert: Biocytogen-B (02315) Surges Over 10% in Afternoon Trade Following Exclusive Licensing Agreement with Qilu Pharmaceutical

Hong Kong Market Pulse | CRO Shares Advance as Order Growth Strengthens; AI-Enabled Drug Discovery Poised to Transform Pharma R&D

Portfolio Alert: HK-Listed CSTONE PHARMA-B Surges 6% on Stock Connect Inclusion and Global Trial Milestones

Hong Kong Stock Market Flash | EVEREST MED Surges Over 5% in Morning Trade as China Approves NDA for PSVT Indication

China Securities Reports Medical Device Sector Sustains Earnings Improvement While Medical Services Revenue Grows Steadily

Hong Kong Stock Market Alert | ALEBUND-B (09637) Surges Over 6% on Stock Connect Inclusion and Index Membership, Mircera Sales Jump Approximately 105% Boosting Commercial Momentum

Major Shift in Sell-Side Research: Healthcare Analyst Switches to Semiconductors

Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Buyback Cancellation

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BK1574/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":485.17123,"timestamp":1789632487194,"preClose":482.35672,"halted":0,"volume":61610930,"delay":0,"changeRate":0.005835,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":2.814514,"latestTime":"09-17 16:00:00","open":482.07187,"high":489.93134,"low":481.40475,"amount":1281540013.5,"amplitude":0.017677,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789695000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789608600000,1789617600000],[1789621200000,1789632000000]],"pbRate":3.604829,"peRate":160.310337,"turnoverRate":0.002293,"increases":18,"decrements":10,"flats":4,"marketCap":307980316848,"floatMarketCap":273827471128},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":489.93134,"amplitude":0.017677,"preClose":482.35672,"low":481.40475,"pbRate":"3.604829","latestPrice":485.17123,"volume":61610930,"delay":0,"open":482.07187,"prevYearClose":556.26263,"prevWeekClose":483.155,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":496.758,"twentyDayClose":517.015,"sixtyDayClose":440.071,"secType":"PLATE","market":"HK","turnoverRate":0.002293,"peRate":160.310337,"marketCap":307980316848,"floatMarketCap":273827471128,"timestamp":1789632487194,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":21,"down":10,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665320213","title":"Hbm9378/Win378, an Ultra-Long-Acting Antibody Targeting Tslp, Achieves Positive Phase 2 Results in Asthma and Initiates Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320213","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665320213?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:17","pubTimestamp":1788869848,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA60HVBV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02142","BK1574","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126663144","title":"Genfleet-B Completes Share Buyback Worth HK$1.54 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1126663144","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126663144?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:11","pubTimestamp":1788869514,"startTime":"0","endTime":"0","summary":"On September 8, 2026, GENFLEET-B (02595) announced that it had repurchased a total of 57,000 shares at a cost of HK$1.5418 million.The buyback was executed in accordance with the company's existing...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1515","02595","BK1161","09939","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190517580","title":"The AI Drug Discovery Sector Enters Its Value-Realization Phase, Unlocking Fresh Growth Avenues for Innovative Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=1190517580","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190517580?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:10","pubTimestamp":1788869456,"startTime":"0","endTime":"0","summary":"The AI-driven pharmaceutical industry has moved past its early-stage concept hype, with validation levels steadily climbing. The narrative has shifted from algorithmic promise to tangible pipeline...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTHR","BK1574","BK1191","QTOC","AGIX","01477","LNGR","BK1161","AIPO","06978","MEDX","IBBQ","ARTY","CHAT","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141807270","title":"ALEBUND-B Wins US FDA Nod to Start Trial of Novel IgA Nephropathy Drug AP308","url":"https://stock-news.laohu8.com/highlight/detail?id=1141807270","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141807270?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:06","pubTimestamp":1788869176,"startTime":"0","endTime":"0","summary":"ALEBUND-B (09637) has announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for AP308, a first-in-class engineered recombinant IgA...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSYK","BK1191","159151","BMED","BK1161","BK1515","BK1574","09939","MDTX","09637","IBBQ","159938","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175433190","title":"Alphamab-B Repurchases 220,000 Shares for HK$1.85 Million on September 8","url":"https://stock-news.laohu8.com/highlight/detail?id=1175433190","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175433190?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:28","pubTimestamp":1788866893,"startTime":"0","endTime":"0","summary":"ALPHAMAB-B (09966) announced that it spent HK$1.8499 million to buy back 220,000 shares on September 8, 2026.The repurchase reflects the company's ongoing commitment to enhancing shareholder value through strategic capital management initiatives.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665323327","title":"Alphamab Oncology Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 8.41","url":"https://stock-news.laohu8.com/highlight/detail?id=2665323327","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665323327?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:25","pubTimestamp":1788866733,"startTime":"0","endTime":"0","summary":"Alphamab Oncology files HKEX next-day return disclosing share repurchase at HKD 8.41Alphamab Oncology repurchased 220,000 shares on Sept. 8 for treasury, no cancellations disclosed.Buyback price range","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL8Tygqr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143453518","title":"Ionis Pharmaceuticals Shares Slide 13.1% in Pre-Market Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1143453518","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143453518?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:20","pubTimestamp":1788866449,"startTime":"0","endTime":"0","summary":"Ionis Pharmaceuticals shares dropped 13.1% in pre-market trading on September 8, according to market data.  The decline reflects a sharp investor reaction to recent developments, though specific...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164928784","title":"ASC36 Obesity Therapy Enters Phase I Trials in the US by Ascletis","url":"https://stock-news.laohu8.com/highlight/detail?id=1164928784","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164928784?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:06","pubTimestamp":1788861983,"startTime":"0","endTime":"0","summary":"Ascletis Pharma-B (01672) has announced the initiation of its Phase I clinical study in the United States for ASC36, an oral amylin receptor agonist peptide designed to treat obesity, following...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1574","01672","BK1161","BK1515","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665932180","title":"Ascletis Pharma - Initiates U.S. Phase I Study for Asc36 Oral Tablets for Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2665932180","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665932180?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:01","pubTimestamp":1788861676,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nFWN44Z0L3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1161","01672","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150107003","title":"Consolidation at the Base Meets Trend Rebound: When Will Kintor Pharma-B Hit the Key Turning Point for a Valuation Recovery?","url":"https://stock-news.laohu8.com/highlight/detail?id=1150107003","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150107003?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:48","pubTimestamp":1788857312,"startTime":"0","endTime":"0","summary":"On the morning of September 7, KINTOR PHARMA-B (09939) announced that its human long-term safety trial for KT-939, a novel and highly effective tyrosinase inhibitor developed in-house to suppress...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1574","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101281013","title":"Nanxin Pharmaceutical Receives Penalty for Disclosure Violations, Affected Investors May Seek Compensation","url":"https://stock-news.laohu8.com/highlight/detail?id=1101281013","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101281013?lang=en_us&edition=fundamental","pubTime":"2026-09-08 15:31","pubTimestamp":1788852662,"startTime":"0","endTime":"0","summary":"Nanxin Pharmaceutical has been found to have disclosed inaccurate financial data in its annual report. On August 13, 2026, the company officially received the Administrative Penalty Decision issued...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1574","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665476053","title":"InnoCare Gets First Half of Remaining Stake Bought in Subsidiary","url":"https://stock-news.laohu8.com/highlight/detail?id=2665476053","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665476053?lang=en_us&edition=fundamental","pubTime":"2026-09-08 14:15","pubTimestamp":1788848135,"startTime":"0","endTime":"0","summary":"InnoCare Pharma  received the first half of the 7% stake of Guangzhou InnoCare Pharma Technology, according to a Shanghai bourse filing on Tuesday.Guangzhou InnoCare completed the changes in its industry and commerce registration after its parent received its 3.5% stake.InnoCare bought the remaining 7% of Guangzhou InnoCare for 476.3 million yuan in August.The pharmaceutical company's shares slipped 1% during the afternoon trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","688428","BK0239","BK1161","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170187220","title":"HK Market Alert: Biocytogen-B (02315) Surges Over 10% in Afternoon Trade Following Exclusive Licensing Agreement with Qilu Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=1170187220","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170187220?lang=en_us&edition=fundamental","pubTime":"2026-09-08 14:00","pubTimestamp":1788847256,"startTime":"0","endTime":"0","summary":"Biocytogen-B (02315) saw its shares jump more than 10% in the afternoon session, last trading up 8.71% at HK$63 with turnover reaching HK$129 million.According to the company's official WeChat...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","BK4585","BK4588","02315","KCAI","688796","BK0216","BK1574","BK1161","VXUS","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134077786","title":"Hong Kong Market Pulse | CRO Shares Advance as Order Growth Strengthens; AI-Enabled Drug Discovery Poised to Transform Pharma R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=1134077786","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134077786?lang=en_us&edition=fundamental","pubTime":"2026-09-08 13:50","pubTimestamp":1788846618,"startTime":"0","endTime":"0","summary":"CRO-related stocks extended their upward momentum into the afternoon session, with Genscript Bio (01548) surging 10.71% to HK$34.32, Asymchem (06821) climbing 8.5% to HK$142.90, Tigermed (03347)...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTOC","BK1576","BK1191","ARTY","HK0000306701.USD","AGIX","BK1583","HK0000306685.HKD","06821","VTHR","VXUS","HK0000320264.USD","JHMH","03759","HK0000320223.HKD","01477","BK1574","01548","BME","BK4585","LRND","KCAI","BK1141","BK4588","AIPO","CHAT","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188251172","title":"Portfolio Alert: HK-Listed CSTONE PHARMA-B Surges 6% on Stock Connect Inclusion and Global Trial Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=1188251172","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188251172?lang=en_us&edition=fundamental","pubTime":"2026-09-08 13:44","pubTimestamp":1788846259,"startTime":"0","endTime":"0","summary":"Portfolio Alert: HK-Listed CSTONE PHARMA-B Surges 6% on Stock Connect Inclusion and Global Trial MilestonesCSTONE PHARMA-B (02616) witnessed a strong afternoon rally on Tuesday, climbing more than 6%...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","FLHK","02616","KCAI","BK1574","161027","VXUS","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167357330","title":"Hong Kong Stock Market Flash | EVEREST MED Surges Over 5% in Morning Trade as China Approves NDA for PSVT Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=1167357330","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167357330?lang=en_us&edition=fundamental","pubTime":"2026-09-08 11:56","pubTimestamp":1788839775,"startTime":"0","endTime":"0","summary":"EVEREST MED (01952) saw its share price climb more than 5% during morning trading on Wednesday. As of the time of writing, the stock was up 4.73% to HK$32.78, with trading turnover reaching HK$151...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","01952","BK1161","BK4588","BK1583","BK1574","IPOS","KCAI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106413707","title":"China Securities Reports Medical Device Sector Sustains Earnings Improvement While Medical Services Revenue Grows Steadily","url":"https://stock-news.laohu8.com/highlight/detail?id=1106413707","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106413707?lang=en_us&edition=fundamental","pubTime":"2026-09-08 11:34","pubTimestamp":1788838468,"startTime":"0","endTime":"0","summary":"China Securities has released a research note indicating that the medical device sector maintained its revenue growth trajectory in Q2, with quarterly profit growth turning positive for the first...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK0276","BK1574","AGNG","LNGR","09996","LGHT","159883","BK1583","GDOC","IEIH","MDEV","601066","PTH","HART","RSPH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183000307","title":"Hong Kong Stock Market Alert | ALEBUND-B (09637) Surges Over 6% on Stock Connect Inclusion and Index Membership, Mircera Sales Jump Approximately 105% Boosting Commercial Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1183000307","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183000307?lang=en_us&edition=fundamental","pubTime":"2026-09-08 10:22","pubTimestamp":1788834140,"startTime":"0","endTime":"0","summary":"ALEBUND-B (09637) shares climbed more than 6% in Monday's session, trading up 6.02% at HK$28.52 as of the time of writing. The stock recorded a turnover of HK$6.452 million with a volume ratio of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK4588","KCAI","BK1574","HSCI","09637","VXUS","FLHK","BK1191","BK1515","159938","BK4585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169256250","title":"Major Shift in Sell-Side Research: Healthcare Analyst Switches to Semiconductors","url":"https://stock-news.laohu8.com/highlight/detail?id=1169256250","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169256250?lang=en_us&edition=fundamental","pubTime":"2026-09-07 22:10","pubTimestamp":1788790245,"startTime":"0","endTime":"0","summary":"Sell-side research has witnessed a notable career pivot as a healthcare-focused analyst has transitioned to covering the electronics sector, marking a significant departure from their academic and...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","KCE","BK1161","159938","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311564","title":"Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Buyback Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311564","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665311564?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:12","pubTimestamp":1788783177,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge files HKEX next-day disclosure return on share buyback cancellationZylox-Tonbridge repurchased 53,500 H shares on Sept. 7, 2026 for holding as treasury shares; no shares were cancelled","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL100F5h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02190","BK1583","BK1100","BK1587"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":9,"totalSize":226,"code":"91000000","status":"200"}]}}